Your skin isn’t just a passive shield—it’s a finely tuned sensor, and scientists have now mapped the full circuit that lets you feel a gentle chill. Researchers at the University of Michigan have identified the first complete neural pathway for sensing cool temperatures, from the skin’s surface to the brain. This research, published in Nature Communications, demonstrates that evolution has designed distinct systems for detecting heat and cold, enabling us to respond precisely to changes in our environment.
“The skin is the body’s largest organ. It helps us detect our environment and separate, distinguish different stimuli,” said Bo Duan, study co-author and associate professor of molecular, cellular and developmental biology. “There are still many interesting questions about how it does this, but we now have one pathway for how it senses cool temperatures. This is the first neural circuit for temperature sensation in which the full pathway from the skin to the brain has been clearly identified.”
From Skin to Spine to Brain
The process begins with specialized molecular thermosensors in the skin, known as transient receptor potential melastatin type 8 (TRPM8) receptors, which detect temperatures between 15°C and 25°C (59°F and 77°F). Once activated, these sensors excite primary sensory neurons, which send the cool signal to the spinal cord. Working with mice, the team discovered a central hub: excitatory interneurons in the spinal dorsal horn that act as an amplifier. These interneurons, identified by their expression of the thyrotropin-releasing hormone receptor, boost the signal before it’s passed to calcitonin receptor-like receptor-positive projection neurons that connect to the brain.
Without this spinal “amplifier,” the message gets lost in background noise, meaning the perception of safe, comfortable coolness fades. The discovery of this amplifier fills a significant gap in scientists’ understanding of thermal perception and reveals a modality-specific pathway dedicated to detecting mild, non-painful cool sensations.
Why It Matters
This research has important implications that extend beyond the question of why an ocean breeze feels refreshing. More than 70% of chemotherapy patients experience painful sensitivity to cold. This study found that the pathway for normal cool sensation differs from the one that triggers cold pain. By understanding the healthy pathway, scientists have a better shot at targeting therapies that restore comfort without impairing normal temperature perception.
Duan’s team also sees potential in exploring how the brain links cool sensations to emotions—why, for example, a breeze on a summer day feels calming, while a winter wind feels punishing. That emotional connection to temperature could be key to understanding behavioral responses that help us avoid danger or seek comfort.
Universal Circuitry
Although the study was conducted in mice, genetic sequencing shows that humans possess the same molecular and neural components. This suggests that the same system likely allows you to savor the feeling of stepping into an air-conditioned room on a sweltering day or enjoy a cool drink against your lips.
The Road Ahead
The team’s next goal is to identify the pathways involved in acute cold pain, which Duan suspects will be more intricate. “I think the painful sensations are going to be more complicated,” Duan said. “When we’re in riskier situations, there could be multiple pathways involved.” Identifying these pathways could open the door to new pain therapies and a better understanding of sensory disorders.
By unraveling the details of our sensory wiring, researchers are not only decoding the language of temperature; they are also laying the groundwork for medical advances that could reduce pain and improve lives.
Did you enjoy this blog post? Check out our other blog posts as well as related topics on our Webinar page.
QPS is a GLP- and GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, preclinical, and clinical drug research development services. Since 1995, it has grown from a tiny bioanalysis shop to a full-service CRO with 1,200+ employees in the US, Europe, Asia, India and Australia. Today, QPS offers expanded pharmaceutical contract R&D services with special expertise in pharmacology, DMPK, toxicology, bioanalysis, translational medicine, cell therapy (including PBMCs, leukopaks and cell therapy products), clinical trial units and clinical research services. An award-winning leader focused on bioanalytics and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction and turnkey laboratories and facilities. Through continual enhancements in capacities and resources, QPS stands tall in its commitment to delivering superior quality, skilled performance and trusted service to its valued customers. For more information, visit www.qps.com or email info@qps.com.
